BioRad Laboratories (BIO)
(Delayed Data from NYSE)
$286.86 USD
+4.85 (1.72%)
Updated May 31, 2024 04:00 PM ET
After-Market: $287.08 +0.22 (0.08%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth F Momentum D VGM
Brokerage Reports
Bio-Rad Laboratories, Inc. [BIO]
Reports for Purchase
Showing records 121 - 140 ( 142 total )
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
We are discontinuing coverage of Bio-Rad Laboratories
Provider: G.RESEARCH, LLC
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Terminating Coverage Due to Analyst Departure.
Provider: COLLIERS SECURITIES
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
BIO: 2Q:12 Soft Top Line and Inline Bottom Line Excl. One Time Expenses
Provider: COLLIERS SECURITIES
Analyst: HUSAIN J
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Medical Technology: Thoughts on Our Medical Technology Universe Heading Into the Dog Days of Summer
Provider: COLLIERS SECURITIES
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
BIO: Slow Start to CY12, Margin Pressure Could Continue in CY13, Fully Valued at These Levels Downgrading to NEUTRAL
Provider: COLLIERS SECURITIES
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
BIO: We Like This Stable Clinical Diagnostics & Life Science Tools Company Initiating Coverage of Bio Rad Laboratories (BIO) with a BUY Rating
Provider: COLLIERS SECURITIES